Barclays PLC ARRIVENT BIOPHARMA INC Transaction History

Barclays PLC

  • $854 Billion
  • Q3 2025
Number of Shares
129,935
Previous 117,212 10.85%
Holding current value
$0
Previous $2.55 Million 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
N/A
12,723 Added 10.85%
129,935 $0
Q2 2025

Aug 13, 2025
BUY
N/A
76,629 Added 188.82%
117,212 $2.55 Million
Q1 2025

May 15, 2025
SELL
N/A
-12,916 Reduced 24.14%
40,583 $751,000
Q4 2024

Feb 13, 2025
BUY
N/A
11,977 Added 28.84%
53,499 $1.43 Million
Q3 2024

Nov 15, 2024
BUY
N/A
38,132 Added 1124.84%
41,522 $976,000
Q2 2024

Aug 14, 2024
SELL
N/A
-10,818 Reduced 76.14%
3,390 $63,000
Q1 2024

May 15, 2024
BUY
N/A
14,208 New
14,208 $254,000
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email